Page 931 - Textbook of Pathology, 6th Edition

infiltrating lobular, 762-63 Carcinoma, thyroid, 811-15 embryonal tumours of, 889 915
inflammatory, 764 Carcinoma, transitional cell, 700-02 infections of, 873-79
intraductal, 760-61 Carcinoma, urinary bladder, 700-02 metabolic diseases of, 885
invasive, 761-65 Carcinoma, vagina, 724 metastatic tumours of, 891
juvenile, 764 staging of, 724t normal structure of, 871-72
lobular in situ, 761 Carcinoma, vulva, 723 nutritional diseases of, 886
medullary, 763 staging of, 723t trauma to, 882-83
mucinous, 763 Cardiac death, sudden, 429f, 436-37 tumours of, 886-91
non-invasive, 760-61 Cardiac oedema, 99, 100f Centrilobular haemorrhagic necrosis, 106, 107f
papillary, 763 Cardiomyopathies, 454t Centriole, 24, 257
prognostic factors in, 766-67 congestive, 454-55 Centromere, 24, 257
secretory, 764 dilated, 454-55 Centrosome, 24
tubular, 763 hypertrophic, 455 Cerebral infarction, 127f, 880-81
Carcinoma, cervix, 58, 207, 224-25, 728-30 idiopathic, 454-56 Cerebral malaria, 189, 313
cytology of, 271-72, 282f ischaemic, 436 Cerebral oedema, 101-02
staging of, 730t restrictive, 455-56 Cerebrospinal fluid (CSF), 873-76
Carcinoma, colorectal, 586-89 secondary, 456 findings in meningitis, 876t
clinical features of, 589 Cardiospasm, 538 cytology of, 276
etiology of, 586 Caries, dental, 528-29 Cerebrovascular disease, 879-82
morphologic features of, 587-88 Caries, spine, 833f, 838 Ceruloplasmin, 628
pathogenesis of, 586-87 Caroli’s disease, 638 Cerumen gland tumour, 514
spread of, 588-89 Carotenaemia, 43 Cervical intraepithelial neoplasia (CIN), 271-72,
staging of, 589, 590f, 591t Carotid body tumour, 521 725-28
Carcinoma, cortical, adrenal, 799 Carrier state, hepatitis, 609-10 Cervicitis, 724-25
Carcinoma, definition of, 192 Cartilage-forming tumours, 843-46 Cervix, 724-30
Carcinoma, embryonal, testis, 710-11 Cartilage normal structure of, 831 carcinoma of, 728-30
Carcinoma, endometrium, 735-37 Caruncle, urethral, 702 normal structure of, 724
staging of, 737t Caseous necrosis, 45, 153, 155-56 tumours of, 725-30
Carcinoma, extra-hepatic duct, 644 Castleman’s disease, 343-44 Chagas’ disease, 187t, 580
Carcinoma, gallbladder, 643-44 Casts, 652 Chalazion, 508
Carcinoma, hepatocellular, 633-36 Cat-scratch disease, 186 Chancre, 162
Carcinoma in situ, 58 Cataract, 510 Charaka, 2
breast, 760-61 Catarrhal inflammation, 144 Charcot-Leyden crystals, 484f
bronchus, 496-503 Catenins, 586-87 Chediak-Higashi syndrome, 349
cervix, 207, 271, 726, 727f Cavitary lesions of lung, 155-56, 156f Chemical carcinogenesis, 216-20
oral cavity, 525-26 C-cells, 816 initiation of, 216-18
skin, 714-15, 782-83 CD markers, 25, 62t, 63-64 initiators of, 219t
urinary bladder, 701 Cell adhesion molecules (CAMs), 25 promoters of, 219t
Carcinoma, kidney, 694-96 Cell aging, 59-60 promoter versus initiator, 220t
Carcinoma, liver, 633-36 Cell cycle, 26-27, 27f promotion of, 218
Carcinoma, lung, 496-504 labile cells in, 166 stages of, 216-20
acinar, 501 permanent cells in, 166 tests for, 220
adenocarcinoma, 500-01 stable cells in, 166 Chemical carcinogens, 219t INDEX
adenosquamous, 501 Cell death, 30-31, 44-53 Chemical injury, 33-34
bronchiolo-alveolar, 501 Cell injury, 21-53 Chemical mediators of inflammation, 136-40
epidermoid, 499-500 chemical, 33-34 Chemoattractants, 134
etiology of,497-98 enzyme markers of, 32t Chemodectoma, 521
pathogenesis of, 498-99 etiology of, 27-28 Chemokines, 26, 134
hilar, 499 free-radical, 31-33 Chemotaxis, 134
large cell, 501 hypoxic, 29-33 Chickenpox, 186
metastatic, 504
oat cell, 500 immunologic, 28, 73-77 Chikungunya, 184
peripheral, 499 irreversible, 30-31 Childhood tumours, 207, 264t, 265t
scar, 500 ischaemic, 29-33 Chlamydiae, 508
small cell, 500 microbial, 28, 174-91 Chloasma, 40
squamous cell, 499-500 morphology of, 34-37 Chloroma, 363
Carcinoma, mucoepidermoid, 536 pathogenesis of, 28-34 Chocolate cyst of ovary, 733
Carcinoma, nasopharyngeal, 225-26, 511-12 physical, 34 Cholangiocarcinoma, 636-37
Carcinoma, nose and paranasal sinuses, 518-19 reperfusion, 31-33 Cholangioma, 633
Carcinoma, oesophagus, 541-43 reversible, 29-30 Cholangitis, 614
Carcinoma, oral cavity, 526-27 Cell membrane, 21-22, 289 primary sclerosing, 626, 627t
Carcinoma, pancreas, 647-48 Cell structure, 21-24 pyogenic, 614
Carcinoma, parathyroid, 818 Cell-mediated reaction, 62t, 63, 77 Cholecystitis, 641-43
Carcinoma, penis, 715-16 Cellular adaptations, 53-59 acute, 641-42
Carcinoma, prostate, 718-19 Cellular swelling, 34-35 chronic, 642
Carcinoma, skin, 783-85, 787-90 Cellulitis, 145 glandularis, 642
Carcinoma, stomach, 555-60 Celsus, 2 Cholecystokinin, 639
clinical features of, 557-58 Cementomas, 532 Choledocholithiasis, 641
etiology of, 555 Cementum, 528 Cholelithiasis (gallstones), 638-41
incidence of, 555 Central nervous system (CNS), 871-91 Cholestasis, 599-600
morphologic features of, 555-57 degenerative diseases of, 884-85 extrahepatic, 599-600
spread of, 557 demyelinating diseases of, 883-84 intrahepatic, 599